These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Atrophy of the corpus callosum associated with cognitive impairment and widespread cortical hypometabolism in carotid artery occlusive disease. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J. Arch Neurol; 1996 Nov; 53(11):1103-9. PubMed ID: 8912483 [Abstract] [Full Text] [Related]
3. Progression of atrophy of the corpus callosum with deterioration of cerebral cortical oxygen metabolism after carotid artery occlusion: a follow up study with MRI and PET. Yamauchi H, Pagani M, Fukuyama H, Ouchi Y, Nagahama Y, Matsuzaki S, Kimura J, Yonekura Y, Konishi J. J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):420-6. PubMed ID: 7561923 [Abstract] [Full Text] [Related]
4. Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases. Yamauchi H, Fukuyama H, Dong Y, Nabatame H, Nagahama Y, Nishizawa S, Konishi J, Shio H. J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):317-22. PubMed ID: 10675213 [Abstract] [Full Text] [Related]
8. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. Teipel SJ, Hampel H, Pietrini P, Alexander GE, Horwitz B, Daley E, Möller HJ, Schapiro MB, Rapoport SI. Arch Neurol; 1999 Apr; 56(4):467-73. PubMed ID: 10199337 [Abstract] [Full Text] [Related]
9. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro MB, Rapoport SI. Arch Neurol; 1998 Feb; 55(2):193-8. PubMed ID: 9482361 [Abstract] [Full Text] [Related]
11. High-intensity area in the deep white matter indicating hemodynamic compromise in internal carotid artery occlusive disorders. Yamauchi H, Fukuyama H, Yamaguchi S, Miyoshi T, Kimura J, Konishi J. Arch Neurol; 1991 Oct; 48(10):1067-71. PubMed ID: 1929899 [Abstract] [Full Text] [Related]
12. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ. J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472 [Abstract] [Full Text] [Related]
13. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J. Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522 [Abstract] [Full Text] [Related]
17. Atrophy of the corpus callosum correlates with white matter lesions in patients with cerebral ischaemia. Meguro K, Constans JM, Courtheoux P, Theron J, Viader F, Yamadori A. Neuroradiology; 2000 Jun 13; 42(6):413-9. PubMed ID: 10929300 [Abstract] [Full Text] [Related]
19. Analysis of cross-sectional area measurements of the corpus callosum adjusted for brain size in male and female subjects from childhood to adulthood. Rauch RA, Jinkins JR. Behav Brain Res; 1994 Oct 20; 64(1-2):65-78. PubMed ID: 7840893 [Abstract] [Full Text] [Related]
20. Atrophy of the corpus callosum in chronic alcoholism. Estruch R, Nicolás JM, Salamero M, Aragón C, Sacanella E, Fernández-Solà J, Urbano-Márquez A. J Neurol Sci; 1997 Mar 10; 146(2):145-51. PubMed ID: 9077511 [Abstract] [Full Text] [Related] Page: [Next] [New Search]